Biotechnology Stock Doubled This: Fund Bets 1.2M Shares
A large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Why Do Active Funds Underperform Benchmark? This overview breaks down fees, manager skill, and market efficiency to explain gaps in performance and how to navigate them.
22,441 articlesA large fund snapped up 1.2 million Vir Biotechnology shares as the stock doubled this past year. Here’s how to read ...
Honda is shifting strategy, moving toward hybrids while still pursuing a carbon-neutral future. This pivot changes ho...
A wave of upgrades is reshaping Near Protocol. Privacy features, AI-ready smart contracts, and scaling improvements c...
When a flagship endowment changes its crypto holdings, it offers a rare peek into risk management. This guide breaks ...
New 2026 SSA data shows the Social Security maximum remains out of reach for most retirees. This article explains why...
In May, sweetgreen stock jumped 45% as the company signaled a path to recovery. This article breaks down the catalyst...
Rocket Lab has surged more than 350% in a year, but investors remain split on the sustainability of the rally as back...
A broad pullback in semiconductors gave way to a cautious rally for Sandisk. This article breaks down what sparked th...
Could MaxLinear be the next stock to 10x? This guide breaks down the company, its AI hardware niche, and the realisti...
As AI accelerates, energy and data infrastructure firms are in the spotlight. Here are two stock ideas that could rid...
Tuesday brought a notable standout in the banking space as JPMorgan Chase topped market momentum. This piece breaks d...
Amazon briefly overtook SpaceX as the world's fifth-largest company by market cap. Here are three reasons that leader...